COVID-19 Vaccination and Glomerulonephritis
-
Published:2021-12
Issue:12
Volume:6
Page:2969-2978
-
ISSN:2468-0249
-
Container-title:Kidney International Reports
-
language:en
-
Short-container-title:Kidney International Reports
Author:
Klomjit NattawatORCID,
Alexander Mariam PriyaORCID,
Fervenza Fernando C.ORCID,
Zoghby Ziad,
Garg Arvind,
Hogan Marie C.ORCID,
Nasr Samih H.,
Minshar Marwan Abu,
Zand Ladan
Reference41 articles.
1. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020
2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021
3. Sahin U, Muik A, Vogler I, et al. BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans. medRxiv. Published December 11, 2020. Accessed July 7, 2021. https://www.medrxiv.org/content/10.1101/2020.12.09.20245175v1.full.pdf
4. In depth evaluation of a case of presumed myocarditis following the second dose of COVID-19 mRNA vaccine;Muthukumar;Circulation,2021
5. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices-United States, June 2021;Gargano;MMWR Morb Mortal Wkly Rep,2021
Cited by
150 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献